(Q46662920)

24 December 2017

title

Conditional survival in ovarian cancer: results from the SEER dataset 1988-2001. (English)

1 reference

24 December 2017

1 reference

2

1 reference

24 December 2017

author name string

Mehee Choi

series ordinal

1

1 reference

24 December 2017

Charles R Thomas

series ordinal

3

1 reference

24 December 2017

Samuel J Wang

series ordinal

4

1 reference

24 December 2017

language of work or name

English

0 references

publication date

7 March 2008

1 reference

24 December 2017

published in

Gynecologic Oncology

1 reference

24 December 2017

volume

109

1 reference

24 December 2017

issue

2

1 reference

24 December 2017

page(s)

203-209

1 reference

24 December 2017

On the estimation of survival

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.033

Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.033

Conditional median survival of patients with advanced carcinoma: surveillance, epidemiology, and end results data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.033

The conditional probability of survival of patients with primary malignant brain tumors: surveillance, epidemiology, and end results (SEER) data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.033

The conditional survival statistics for survivors with primary supratentorial astrocytic tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.033

The conditional probabilities of survival in patients with anaplastic astrocytoma or glioblastoma multiforme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.033

Conditional survival in head and neck squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.033

Conditional survival of 56,268 patients with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.033

Ethnicity and conditional breast cancer survival in Hawaii

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.033

Can the survival difference between breast cancer patients in Denmark and Sweden 1989 and 1994 be explained by patho-anatomical variables?--a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.033

Conditional survival among patients with carcinoma of the lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.033

Conditional survival of patients with the four major histologic subgroups of lung cancer in Denmark.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.033

Ethnic disparities in conditional survival of patients with non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.033

Conditional survival in gastric cancer: a SEER database analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.033

Conditional survival estimates in 34,963 patients with invasive carcinoma of the colon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.033

Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.033

Ethnic differences in survival among women with ovarian carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.033

End points for adjuvant therapy trials: has the time come to accept disease-free survival as a surrogate end point for overall survival?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.033

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.033

Current management strategies for ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.033

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.033

Influence of death certificate errors on cancer mortality trends

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.033

A Nomogram for Predicting the Likelihood of Additional Nodal Metastases in Breast Cancer Patients With a Positive Sentinel Node Biopsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.033

Use of nomograms to predict the risk of disease recurrence after definitive local therapy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.033

Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.033

Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.033

10.1016/J.YGYNO.2008.01.033

7 January 2021

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017